Your browser doesn't support javascript.
loading
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.
Dafni, U; Michielin, O; Lluesma, S Martin; Tsourti, Z; Polydoropoulou, V; Karlis, D; Besser, M J; Haanen, J; Svane, I-M; Ohashi, P S; Kammula, U S; Orcurto, A; Zimmermann, S; Trueb, L; Klebanoff, C A; Lotze, M T; Kandalaft, L E; Coukos, G.
Affiliation
  • Dafni U; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland; Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece.
  • Michielin O; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland.
  • Lluesma SM; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Tsourti Z; Scientific Research Consulting Hellas, Statistics Center, Athens.
  • Polydoropoulou V; Scientific Research Consulting Hellas, Statistics Center, Athens.
  • Karlis D; Department of Statistics, Athens University of Economics and Business, Athens, Greece.
  • Besser MJ; Ella Institute for the Treatment and Research of Melanoma and Skin Cancer, Sheba Medical Center, Tel Aviv; Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Haanen J; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Svane IM; Department of Hematology and Oncology, Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark.
  • Ohashi PS; Department of Immunology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Kammula US; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh.
  • Orcurto A; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland.
  • Zimmermann S; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland.
  • Trueb L; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland.
  • Klebanoff CA; Center for Cell Engineering and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Parker Institute for Cancer Immunotherapy, New York; Weill Cornell Medical College, New York.
  • Lotze MT; Department of Immunology, University of Pittsburgh Schools of the Health Sciences, Pittsburgh, USA.
  • Kandalaft LE; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Coukos G; Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. Electronic address: george.coukos@chuv.ch.
Ann Oncol ; 30(12): 1902-1913, 2019 12 01.
Article in En | MEDLINE | ID: mdl-31566658
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Recombinant Proteins / Lymphocytes, Tumor-Infiltrating / Interleukin-2 / Melanoma Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Grecia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Recombinant Proteins / Lymphocytes, Tumor-Infiltrating / Interleukin-2 / Melanoma Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Grecia